Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
Fat is the primary target
These drugs are primarily approved for treating type 2 diabetes, so coverage is usually only available if a patient with PCOS also has type 2 diabetes or obesity as a related condition
Early trials of adjunctive therapies The first GLP-1 receptor agonist, Byetta (exenatide), was approved in the early 2000s
This action can assist in reducing skin discolouration and pigmentation, contributing to a more even skin tone
US$ 24.92
US$ 29.13
US$ 29.37
US$ 26.11
US$ 22.32
US$ 23.81
